{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&min-ddpModified.=2018-11-20T15%3A35%3A09.926Z&max-answer.dateOfAnswer=2018-11-20", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&min-ddpModified.=2018-11-20T15%3A35%3A09.926Z&max-answer.dateOfAnswer=2018-11-20", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&_metadata=all&min-ddpModified.=2018-11-20T15%3A35%3A09.926Z&max-answer.dateOfAnswer=2018-11-20", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&_page=0&min-ddpModified.=2018-11-20T15%3A35%3A09.926Z&max-answer.dateOfAnswer=2018-11-20", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&min-ddpModified.=2018-11-20T15%3A35%3A09.926Z&max-answer.dateOfAnswer=2018-11-20", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&min-ddpModified.=2018-11-20T15%3A35%3A09.926Z&max-answer.dateOfAnswer=2018-11-20", "items" : [{"_about" : "http://data.parliament.uk/resources/1007762", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1007762/answer", "answerText" : {"_value" : "<p>Dementia remains a key priority for the Government. We will implement the Prime Minister\u2019s Challenge on Dementia 2020 (published in February 2015) in full to make sure the lives of those with dementia are transformed by 2020.<\/p><p> <\/p><p>Working with our partners, we continue to make progress against the ambitions set in the March 2016 Implementation Plan which details how the commitments in the Challenge, across the four core themes of risk reduction, health and care, awareness and social action, and research will be met. This is reflected in the specific expectation set in the mandate to NHS England 2018/19 that two thirds of people living with dementia should receive a formal diagnosis. As of October 2018, the dementia diagnosis rate was 67.9%.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"}
        }
        , "answeringMemberConstituency" : {"_value" : "Gosport"}
        , "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"}
        , "dateOfAnswer" : {"_value" : "2018-11-20", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-11-20T15:37:58.543Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-11-15", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Dementia"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether he has targets for improvements to care and services for people with dementia over the period of this Parliament.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1409", "label" : {"_value" : "Biography information for Mr Gregory Campbell"}
      }
      , "tablingMemberConstituency" : {"_value" : "East Londonderry"}
      , "tablingMemberPrinted" : [{"_value" : "Mr Gregory Campbell"}
      ], "uin" : "191881"}
    , {"_about" : "http://data.parliament.uk/resources/1007772", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1007772/answer", "answerText" : {"_value" : "<p>In line with the guidance governing research, the HIV Pre-Exposure Prophylaxis (PrEP) Impact Trial is currently unable to provide any detailed breakdown of information about participants. This is to preserve the integrity of the emerging data. A planned interim analysis including further demographic breakdown is planned early next year.<\/p><p> <\/p><p>An evaluation report will be available after the completion of the trial in 2021 which is expected to include the facilitators and barriers to accessing HIV pre-exposure prophylaxis across all groups, including women.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2018-11-20", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "191930"}
        , {"_value" : "191931"}
        , {"_value" : "191932"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-11-20T15:03:05.303Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-11-15", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "HIV Infection: Drugs"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 21 June 2018 to Question 153280 on HIV Infection: Drugs, if he will publish the review of risk factors and associated vulnerabilities among women recruited to the trial.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4267", "label" : {"_value" : "Biography information for Sarah Champion"}
      }
      , "tablingMemberConstituency" : {"_value" : "Rotherham"}
      , "tablingMemberPrinted" : [{"_value" : "Sarah Champion"}
      ], "uin" : "191929"}
    , {"_about" : "http://data.parliament.uk/resources/1007773", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1007773/answer", "answerText" : {"_value" : "<p>In line with the guidance governing research, the HIV Pre-Exposure Prophylaxis (PrEP) Impact Trial is currently unable to provide any detailed breakdown of information about participants. This is to preserve the integrity of the emerging data. A planned interim analysis including further demographic breakdown is planned early next year.<\/p><p> <\/p><p>An evaluation report will be available after the completion of the trial in 2021 which is expected to include the facilitators and barriers to accessing HIV pre-exposure prophylaxis across all groups, including women.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2018-11-20", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "191929"}
        , {"_value" : "191931"}
        , {"_value" : "191932"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-11-20T15:03:05.35Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-11-15", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "HIV Infection: Drugs"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 21 June 2018 to Question 153280 on HIV Infection: drugs, if he will publish the outcome of the interviews with women to explore the facilitators and barriers to accessing the HIV pre-exposure prophylaxis.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4267", "label" : {"_value" : "Biography information for Sarah Champion"}
      }
      , "tablingMemberConstituency" : {"_value" : "Rotherham"}
      , "tablingMemberPrinted" : [{"_value" : "Sarah Champion"}
      ], "uin" : "191930"}
    , {"_about" : "http://data.parliament.uk/resources/1007820", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1007820/answer", "answerText" : {"_value" : "<p>We understand from NHS England that no women registered in Oxfordshire and Oxford West and Abingdon constituency were affected by the recent failure to send out cervical screening invitation and reminder letters between January and June 2018.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2018-11-20", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-11-20T15:04:42.557Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-11-15", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cervical Cancer: Screening"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of women in (a) Oxfordshire and (b) Oxford West and Abingdon constituency who did not receive a cervical screening invitation and reminder letter between January and June 2018.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4656", "label" : {"_value" : "Biography information for Layla Moran"}
      }
      , "tablingMemberConstituency" : {"_value" : "Oxford West and Abingdon"}
      , "tablingMemberPrinted" : [{"_value" : "Layla Moran"}
      ], "uin" : "191987"}
    , {"_about" : "http://data.parliament.uk/resources/1007861", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1007861/answer", "answerText" : {"_value" : "<p>Following the recent cervical screening incident, announced on 15 November 2018, NHS England has set up a multi-agency clinical panel to manage the incident. Capita has put in place daily audits to ensure all women\u2019s files are accounted for and are looking at how automated processes can be used to reduce errors. Additionally, the checks within the Capita call and recall service have been upgraded at every stage of the process and Capita has appointed an independent audit team to carry out a detailed review into operation systems and processes in Primary Care Support England.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2018-11-20", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-11-20T15:05:38.193Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-11-15", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cervical Cancer: Screening"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the whether the cervical screening programme IT system is fit for purpose.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4342", "label" : {"_value" : "Biography information for Liz McInnes"}
      }
      , "tablingMemberConstituency" : {"_value" : "Heywood and Middleton"}
      , "tablingMemberPrinted" : [{"_value" : "Liz McInnes"}
      ], "uin" : "191937"}
    , {"_about" : "http://data.parliament.uk/resources/1005988", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1005988/answer", "answerText" : {"_value" : "<p>The Government is committed to reducing public health harms caused by smoking and has consistently highlighted that quitting smoking and nicotine use is the best way to improve health. E-cigarettes are not risk free. However, the evidence is increasingly clear that vaping is significantly less harmful to health than smoking tobacco and can be particularly useful in supporting smokers to quit, especially when combined with stop smoking services.<\/p><p> <\/p><p>The most recent evidence report review from Public Health England, published on 6 February 2018, argues that e-cigarette use, alone or in combination with licensed medication and behavioural support from a stop smoking service appears to be helpful in the short-term, and that e-cigarettes have contributed to tens of thousands of additional quitters in England.<\/p><p> <\/p><p>The Department will continue to monitor the impact of regulation and policy on e-cigarettes and novel tobacco products in England, including evidence on safety, uptake, health impact and effectiveness of these products as smoking cessation aids, to inform our future policy.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2018-11-20", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-11-20T15:10:02.103Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-11-13", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Electronic Cigarettes"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what the implications are for his policies of the evidence from Public Health England and Cancer Research UK that one of the most effective ways to stop smoking is to use vape products.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
      }
      , "tablingMemberConstituency" : {"_value" : "Strangford"}
      , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
      ], "uin" : "190884"}
    , {"_about" : "http://data.parliament.uk/resources/1005989", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1005989/answer", "answerText" : {"_value" : "<p>Nicotine shots are regulated under the Tobacco and Related Products Regulation 2016 as they are a nicotine containing product. As shortfills do not contain nicotine when sold they are not regulated under the Tobacco and Related Products Regulations 2016 (TRPR), but are covered by General Product Safety Regulations.<\/p><p> <\/p><p>The Government is committed to conduct a review of the TRPR at a later date.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2018-11-20", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-11-20T15:08:46.447Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-11-13", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Electronic Cigarettes"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment his Department has made of  the effectiveness of the regulation of non-nicotine liquid for vape products and nicotine shots.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
      }
      , "tablingMemberConstituency" : {"_value" : "Strangford"}
      , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
      ], "uin" : "190885"}
    , {"_about" : "http://data.parliament.uk/resources/1006014", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1006014/answer", "answerText" : {"_value" : "<p>Many people with gambling problems will receive treatment from the National Health Service. There are a range of services available to problem gamblers, details of which can be found on the NHS Choices website at the following link:<\/p><p> <\/p><p><a href=\"http://www.nhs.uk/Livewell/addiction/Pages/gamblingaddiction.aspx\" target=\"_blank\">www.nhs.uk/Livewell/addiction/Pages/gamblingaddiction.aspx<\/a><\/p><p> <\/p><p>Specialist facilities are provided through industry funding. Central and North West London NHS Foundation Trust has a national problem gambling clinic which accepts referrals from all over the United Kingdom. Further details are available at the following link:<\/p><p> <\/p><p><a href=\"http://www.cnwl.nhs.uk/cnwl-national-problem-gambling-clinic/\" target=\"_blank\">http://www.cnwl.nhs.uk/cnwl-national-problem-gambling-clinic/<\/a><\/p><p> <\/p><p>The National Institute for Health and Care Excellence has been commissioned to explore developing a guideline on non-chemical addictions, including gambling, which will give support to clinicians seeking to support problem gamblers.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2018-11-20", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-11-20T15:11:33.977Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-11-13", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Gambling"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, if his Department will make an assessment of the effectiveness of the NHS in supporting people who have a gambling addiction.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1198", "label" : {"_value" : "Biography information for Sir David Evennett"}
      }
      , "tablingMemberConstituency" : {"_value" : "Bexleyheath and Crayford"}
      , "tablingMemberPrinted" : [{"_value" : "Sir David Evennett"}
      ], "uin" : "190799"}
    , {"_about" : "http://data.parliament.uk/resources/1006074", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1006074/answer", "answerText" : {"_value" : "<p>\u2018Prescribed Medicines: An Evidence Review\u2019 is a public health evidence review of the published evidence and available data. This process is distinct from a public inquiry so the inclusion of individual testimonies would not be appropriate.<\/p><p> <\/p><p>Public Health England (PHE) is aware of the importance and relevance of the experience of patients in understanding the issues. The review will give significant prominence to the patients\u2019 experiences and examine existing service models through published research and other methods, for example analysis of annual reports of various withdrawal charities.<\/p><p> <\/p><p>The call for evidence was open to all parties, including pharmaceutical companies. The call for evidence has now closed. The National Guideline Centre (NGC) will provide details on the evidence submitted in their rapid evidence assessment report. The report is due in early 2019.<\/p><p> <\/p><p>A non-disclosure agreement was not made between PHE and the NGC in relation to the review of literature on prescribed medicines.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2018-11-20", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "190914"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-11-20T15:07:46.427Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-11-13", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Prescription Drugs"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 24 October 2018 to Question 180245 on Prescription Drugs, for what reason his Department did not include individual testimony; and what proportion of the published evidence was submitted by pharmaceutical companies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4436", "label" : {"_value" : "Biography information for Cat Smith"}
      }
      , "tablingMemberConstituency" : {"_value" : "Lancaster and Fleetwood"}
      , "tablingMemberPrinted" : [{"_value" : "Cat Smith"}
      ], "uin" : "190913"}
    , {"_about" : "http://data.parliament.uk/resources/1006075", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1006075/answer", "answerText" : {"_value" : "<p>\u2018Prescribed Medicines: An Evidence Review\u2019 is a public health evidence review of the published evidence and available data. This process is distinct from a public inquiry so the inclusion of individual testimonies would not be appropriate.<\/p><p> <\/p><p>Public Health England (PHE) is aware of the importance and relevance of the experience of patients in understanding the issues. The review will give significant prominence to the patients\u2019 experiences and examine existing service models through published research and other methods, for example analysis of annual reports of various withdrawal charities.<\/p><p> <\/p><p>The call for evidence was open to all parties, including pharmaceutical companies. The call for evidence has now closed. The National Guideline Centre (NGC) will provide details on the evidence submitted in their rapid evidence assessment report. The report is due in early 2019.<\/p><p> <\/p><p>A non-disclosure agreement was not made between PHE and the NGC in relation to the review of literature on prescribed medicines.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2018-11-20", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "190913"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-11-20T15:07:46.48Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-11-13", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Prescription Drugs"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care,  whether a non-disclosure agreement was made between Public Health England and the National Guideline Centre in relation to the review of literature on prescribed medicines.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4436", "label" : {"_value" : "Biography information for Cat Smith"}
      }
      , "tablingMemberConstituency" : {"_value" : "Lancaster and Fleetwood"}
      , "tablingMemberPrinted" : [{"_value" : "Cat Smith"}
      ], "uin" : "190914"}
    ], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&_page=1&min-ddpModified.=2018-11-20T15%3A35%3A09.926Z&max-answer.dateOfAnswer=2018-11-20", "page" : 0, "startIndex" : 1, "totalResults" : 32, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}